Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 3897  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page

    Article Cited by others


Apremilast coadministered with secukinumab for safe and effective control of psoriasis with resultant reduction of maintenance dose of the biologic

De Abhishek, Das Sudip, Dhoot Dhiraj, Sarda Aarti

Year : 2019| Volume: 64| Issue : 3 | Page no: 239-241

   This article has been cited by
1 Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review
Mette Gyldenløve, Farzad Alinaghi, Claus Zachariae, Lone Skov, Alexander Egeberg
American Journal of Clinical Dermatology. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios
Murlidhar Rajagopalan, Sunil Dogra, Abir Saraswat, Sachin Varma, Pravin Banodkar
Psoriasis: Targets and Therapy. 2021; Volume 11: 109
[Pubmed]  [Google Scholar] [DOI]
3 Systematic Review and Recommendations to Combine Newer Therapies With Conventional Therapy in Psoriatic Disease
Sandeep Arora, Pankaj Das, Gulhima Arora
Frontiers in Medicine. 2021; 8
[Pubmed]  [Google Scholar] [DOI]


Read this article